Related to The Status of U.S. and European Government Funding for Synthetic Biology

• Gene-Synthesis Firms Set Up Biosecurity Protocol
  
• Report Highlights Biotech Strengths, Opportunities, and Weaknesses in Newest EU Countries
  
• $25M NSF Center Set Up to Investigate Complex Biological Systems
  
• DNA2.0 and Blue Sky Biotech Forge Pact to Provide Services from Gene Synthesis to Purified Protein
  
• First Replicating Cell Driven by Synthetic Genome Created by Venter Institute
  
• Report Confirms Biotech Struggling in the Face of Volatile Capital Markets
  
• Report Reveals Growth Opportunities in the Immunoassay Market
  
• Top NIH Grants for 2009
  
• Diabetes Therapy Company Poxel Raises $21M in Series A Financing
  
• Cara Raises $15M in Series D Fundraising for Phase II Development of Pain Relief Drug
  
• Cerenis Raises €40M in Series C and Wins €10.7M from French Government
  
• OriGene Picks Up Gene-Synthesis Firm Blue Heron Biotechnology
  
• Belgian Tech-Transfer Organization Gets Additional €16M from K.U. Leuven and EIF
  
• Novartis Teams with Synthetic Genomics Vaccines to Develop Flu Seed Virus Banks
  
• Tate & Lyle to Manufacture Farnesene for Amyris
  
• Presidential Bioethics Commission Releases Review of Synthetic Biology
  
• Intrexon Makes $11.63M Equity Payment in Ziopharm as Part of DNA-Based Anticancer Drug Deal
  
• Synthetic Proteins that Sustain Life Created
  
• Scientists Generate Pneumococcal Serotype 3 Vaccine Using Synthetic Toxin Gene
  
• IAVI Partners with Indian Government Institute for Broad-Spectrum HIV Vaccine Initiative